Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastrointest Surg. Jan 27, 2016; 8(1): 5-26
Published online Jan 27, 2016. doi: 10.4240/wjgs.v8.i1.5
Table 6 Meta-analysis published comparing open vs laparoscopic liver resection
Ref.No. of studies/periodType of studiesEnd pointNo. of OLR × LLRConversion rateFavors ORLFavors LLREqual OLR × LLR
Simillis et al[151]8ObservationalShort-term outcomes244 (59.7%) × 165 (40.3%)3.7%Need and duration of portal clampingOperative blood lossBlood transfusion rate
NonrandomizedReturn to oral intakeOperative time
ComparativeLOSIncidence of portal triad clamping
1998-2005Benign and malignant diseaseAdverse events
Oncologic clearance
Croome et al[150]26ObservationalShort and long-term outcomes1019 (53.9%) × 871 (46.1%)3.5%Lower risk of margins smaller than 1 cmOperative blood lossBlood transfusion rate
NonrandomizedReturn to oral intakeOperative time
ComparativeNeed for intravenous narcoticsIncidence of portal triad clamping
1998-2009Benign and malignant diseaseOverall complication rateOncologic clearance
All cause mortality in 2-5 yrRecurrence risk
Mirnezami et al[149]26ObservationalShort and long-term outcomes961 (57%) × 717 (43%)7%Operative timeOperative blood lossPortal trial clamping time
NonrandomizedReturn to oral intakeMargin size
ComparativeOverall and specific complicationsHepatic tumor recurrence for HCC
1998-2009Benign and malignant diseaseIncidence of portal triad clampingDFS for HCC
Lower risk of margins smaller than 1 cm
Lower rate of positive margins
Increased overall survival for HCC
Zhou et al[118]10ObservationalShort and long-term outcomes281 (56.9%) × 213 (43.1%)6.1%-Operative blood lossOperative time
NonrandomizedBlood transfusion ratePostoperative mortality
ComparativeOverall and liver specific complicationsSize of resection margins
2001-2010HCC onlyLOSDFS
Overall survival
Mizuguchi et al[152]11ObservationalShort-term outcomes253 (52.2%) × 232 (47.8%)NR-Operative blood lossOperative time
NonrandomizedPostoperative complications
ComparativeLOS
2001-2008Benign and malignant disease
Fancellu et al[111]9ObservationalShort and long-term outcomes363 (61.5%) × 227 (38.5%)4%-Rate of positive marginsLiver haemorrhage
NonrandomizedOperative blood lossBile leakage
ComparativeBlood transfusion rateOS
2001-2010HCC onlyLOSDFS
Overall and liver specific complications
Rao et al[94]7ObservationalShort-term outcomes111 (45.3%) × 134 (54.7%)2.7%-Postoperative complicationsOperative blood loss
NonrandomizedOperative timeBlood transfusion rate
2005-2009Comparative only patients undergoing laparoscopic × open LLSLOSRate of positive margins
Li et al[173]10ObservationalShort and long-term outcomes383 (61%) × 244 (39%)6.6%-Operative blood lossOperative time
NonrandomizedBlood transfusion rateSurgical margin size
ComparativePostoperative complicationsRate of positive margins
2001-2011HCC onlyLOSTumor recurrence
Rao et al[148]32ObservationalShort and long-term outcomes1305 (52.9%) x 1161 (47.1%)2.3%Operative timeOperative blood lossOverall and liver specific complications
NonrandomizedBlood transfusion rateOperative mortality
ComparativeLOSMargin width
1998-2009Benign and malignant diseaseReturn to oral intakeDFS
Rate of positive marginsOS
Overall complication rateRecurrence rate
Xiong et al[117]15ObservationalShort and long-term outcomes316 (57.5%) × 234 (42.5%)0% to 19.4%-Operative blood lossOperative time
NonrandomizedBlood transfusion ratePulmonary complications
ComparativeLOSBleeding
2001-2011HCC onlyIncidence of liver failure and ascitesBile leakage
Operative mortality
Rate of positive margins
Tumor recurrence
Rao et al[172]10ObservationalShort-term outcomes404 (57.7%) × 296 (42.3%)NR-Operative blood lossOperative time
NonrandomizedBlood transfusion rateAscitis
2002-2009ComparativeNegative margins ratePostoperative liver failure
Malignant tumorsOverall complication rateDFS
LOSOS
Recurrence rate
Yin et al[174]15ObservationalShort and long-term outcomes753 (60.8%) × 485 (39.2%)2.6%-Operative blood lossSurgical margins
NonrandomizedBlood transfusion rateOperative time
ComparativePostoperative morbidityNegative margins rate
2001-2011HCC onlyLOSRecurrence rate
OS
RFS
Zhou et al[129]8ObservationalShort and long-term outcomes427 (61.4%) × 268 (38.6%)8.2%-Operative blood lossOperative time
NonrandomizedBlood transfusion rate
ComparativePostoperative morbidity
2002-2013CRLM onlyLOS
Negative margin
OS
DFS
Twaij et al[168]4ObservationalShort and long-term outcomes270 (64.3%) × 150 (35.7%)7% to 19.4%-Surgical margin sizeOperative time
NonrandomizedOperative blood lossOS
ComparativeBlood transfusion rateDFS
2009-2013HCC only with cirrhosisPostoperative morbidity
Parks et al[167]15ObservationalShort and long-term outcomes556 (55.5%) × 446 (44.5%)4.2%-Operative blood lossOperative time
NonrandomizedLOS30-d mortality
ComparativeOS
2001-2011Malignant tumors
Luo et al[128]7ObservationalShort and long-term outcomes383 (61.4%) × 241 (38.6%)NRMargin sizeOperative blood lossOperative time
NonrandomizedBlood transfusion rateLOS
ComparativePostoperative complicationsOS
2002-2013CRLM onlyRate of R1 marginsDFS
Wei et al[127]14ObservationalShort and long-term outcomes599 (61.4%) × 376 (38.6%)NR-Operative blood lossOperative time
NonrandomizedBlood transfusion ratePerioperative mortality
2002-2013ComparativeLOSOS
CRLM onlyPostoperative complicationsDFS
13 studies comparing simultaneous
laparoscopic × open resections1Simultaneous resection1Simultaneous resection
LOSMorbidity, operative time, operative blood loss
Schiffman et al[130]8ObservationalShort and long-term outcomes368 (60.3%) × 242 (39.7%)NR-Operative blood lossOperative time
NonrandomizedBlood transfusion rateNumber of major resections
ComparativeOverall complication rateMean number of resected tumors
2009-2013CRLM onlyLOSTumor size
Positive margins
Margin width
OS
DFS
Jackson et al[153]46ObservationalShort-term outcomes1741 (47.8%) × 1901 (52.2%)5.68%CostOperative blood lossOperative time
NonrandomizedNegative margin30-d mortality
2001-2013ComparativeLOS
Benign and malignant diseasePostoperative complications
Morise et al[169]21ObservationalAscitis602 (63.1%)NR-Less ascites-
Nonrandomized× 352 (36.9%)Less postoperative liver failure
2001-2014Comparative
HCC onlyPostoperative liver failure220 (54.6%) × 183 (45.7%)